Dopamine News and Research

Latest Dopamine News and Research

Gene-based therapy successful in Parkinson's disease

Brain scans have revealed that the first gene-based therapy for Parkinson's disease was effective.

20 Nov 2007

University of Illinois at Chicago receives $2.2 million grant to develop drugs to suppress cocaine cravings

The University of Illinois at Chicago College of Pharmacy has received a $2.2 million federal grant to develop therapeutics to suppress the cravings of cocaine addicts.

19 Nov 2007

Common painkillers may prevent Parkinson's disease

Researchers in the U.S. are suggesting that painkillers such as ibuprofen and naproxen can cut the risk of Parkinson's disease by as much as 60%.

6 Nov 2007

Saint Louis University scientists identify chemical that triggers Parkinson's disease

Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease - a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders.

30 Oct 2007

Deep brain stimulation to treat Parkinson's makes some act irrationally

An implantable brain device meant to help Parkinson's disease patients better control their movements, has been found to have some worrying side-effects.

29 Oct 2007

Teenage smokers at risk of depression, alcohol abuse and drug use

According to American researchers smoking cigarettes may make teens more prone to depression, alcohol abuse and illegal drug use.

28 Oct 2007

Sigma-Aldrich and Oxford BioMedica win key ruling in Open Biosystems patent case

Sigma-Aldrich and Oxford BioMedica have announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich.

25 Oct 2007

More evidence dopamine plays a role in obesity

A brain-imaging study of genetically obese rats conducted at the U.S. Department of Energy's Brookhaven National Laboratory provides more evidence that dopamine - a brain chemical associated with reward, pleasure, movement, and motivation - plays a role in obesity.

25 Oct 2007

Why some succumb to stress - new brain mechanism identified

Results of a new study may one day help scientists learn how to enhance a naturally occurring mechanism in the brain that promotes resilience to psychological stress.

19 Oct 2007

Mice offer clues to the roots of human resilience

When faced with adversity, some people succumb to debilitating psychological diseases including posttraumatic stress disorder and depression, while others are able to remain remarkably optimistic.

19 Oct 2007

Study looks at sepsis and purpura in children

While survival rates for sepsis have increased over the past two decades, children under four and those in adolescence remain highly susceptible to the condition.

18 Oct 2007

Insulin levels affect the brain's dopamine systems

Insulin, long known as an important regulator of blood glucose levels, now has a newly appreciated role in the brain.

18 Oct 2007

Insulin signaling and amphetamines

Abuse of psychostimulants such as amphetamine remains a serious public health concern.

17 Oct 2007

People with lower dopamine levels eat more

Science has found one likely contributor to the way that some folks eat to live and others live to eat.

15 Oct 2007

Dopamine levels and appetite

Science has found one likely contributor to the way that some folks eat to live and others live to eat.

15 Oct 2007

The highs and lows of drug cravings

The anticipation of a cocaine fix and the actual craving to abuse the drug are two closely related phenomena, according to new evidence published in the online open access journal Substance Abuse Treatment, Prevention, and Policy.

11 Oct 2007

Genetics and learning

New research is giving scientists fresh insights into how genetics are a prime factor in how we learn.

2 Oct 2007

Vanda Pharmaceuticals submits iloperidone NDA

Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.

27 Sep 2007

Stem-cell therapy opens new avenue of research against Huntington's disease

Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease – a fatal disorder for which there is currently no cure or even a treatment to slow the disease.

26 Sep 2007

New nanoprobe imaging station helps study the distribution of elements in cells

Scientists suspect that iron accumulation plays a role in neurodegenerative processes such as Parkinson's disease, but its distribution in neurons has never been observed because of the lack of techniques to do so. Until today.

26 Sep 2007